The objective of the Fund is to provide returns over a period of at least 5 years by a combination of capital growth and income generation. The Investment Manager will manage the portfolio in order to ...

The objective of the Fund is to maximise potential total return (i.e. capital and income growth). The Investment Manager will manage the portfolio in order to achieve its investment objective by ...

The objective of the Fund is to maximise potential total return (i.e. capital and income growth). The Investment Manager will manage the portfolio in order to achieve its investment objective by ...

This fund can be held in an Investment ISA, SIPP and Investment Account The Fund aims to provide returns over the medium to long term (3 - 5 years) by a combination of both capital growth and income ...

Iovance Biotherapeutics Inc is a biopharmaceutical company in the United States. Its lead pipeline candidate, LN-144, uses the tumor-infiltrating lymphocytes to treat serious diseases.

The Fund seeks to provide investors with a total return, taking into account capital and income returns, which reflects the return of an equity index, the NASDAQ AlphaDEX® Large Cap Core Index (the ...

The investment objective of the Fund is to achieve an investment return (capital growth and reinvestable income) over the longer term (5 years+). The Fund will be actively managed to achieve its ...

Goldman Sachs Group Inc is engaged in capital market activities. Its services primarily include investment banking operations.

Willis Towers Watson PLC is a global advisory, insurance brokerage, and solutions company worldwide.

BP PLC is an integrated oil and gas company. Its business activities involved oil and natural gas exploration, midstream transportation, supply and trading of crude oil, petrochemicals products and ...

Rolls-Royce Holdings PLC is a pre-eminent engineering company. The group is organised into five customer-facing businesses: Civil Aerospace, Defence Aerospace, Power Systems, Marine and Nuclear.